Buy or sell TeselaGen stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

TeselaGen Stock
TeselaGen is accelerating the design and fabrication of DNA with synthetic biology software.
About TeselaGen Stock
TeselaGen is building a rapid prototyping system for fast bio-based construction of sustainably sourced chemicals, therapeutic medicines, and novel vaccines. Their customers are biopharmaceutical and bioindustrial companies like Amgen and Genomatica. Their bioCAD/CAM system is based on technology exclusively licensed from Lawrence Berkeley National Lab and is being beta tested by hundreds of users.
Management
Founder and Chief Scientific Officer
Nathan Hillson
Founder & CEO
Michael Fero
Founder & CTO
Eduardo Abeliuk
Team Member
Nick Elsbree
Press
TeselaGen Is Building A Platform For Rapid Prototyping in Synthetic Biology
TechCrunch - Mar, 10 2014
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase